Kevetrin and Prurisol results should be released before adding all the money now. $40M is significant dilution at this price. We have enough money to start the trial and get the results on those other two out. The lawsuit being dropped would help too and we have time to accomplish that (march-april).
If we were at $4 I'd be all for tapping out Aspire. At $1.15...not so much.